Results 111 to 120 of about 7,137 (182)

Clinical Profile, Humanistic and Economic Burden of Paroxysmal Nocturnal Hemoglobinuria in Patients Treated With C5 Inhibitors. [PDF]

EJHaem
Gandhi S, Radsak MP, Ueda Y, Balp MM, Wiyani A, Somenzi O, Snellman J, Taylor Y, Simons A, Panse J.   +9 more
europepmc   +1 more source

Paroxysmal Nocturnal Hemoglobinuria in Patients with Systemic Lupus Erythematosus: Diagnostic Challenges and Improvement with C5 Inhibitor Treatment. [PDF]

Intern Med
Nakata Y, Mori T, Nogami A.
europepmc   +1 more source

Improved Iron Overload with Pegcetacoplan in Eculizumab-Experienced Patients with Paroxysmal Nocturnal Hemoglobinuria. [PDF]

Int J Mol Sci
Shammo J, Hillmen P, Blandino P, Abilash V, Kuter DJ.   +4 more
europepmc   +1 more source

Concurrent Superior Mesenteric and Splenic Vein Thrombosis in a Prothrombin G20210A Carrier: Radiologic Evolution and Resolution on Apixaban. [PDF]

Cureus
Ahmad CM, Kastle RA, Gharavi Alkansari N, Sheridan PT, Dalia S.   +4 more
europepmc   +1 more source

Hepatic Sinusoidal Obstruction Syndrome Secondary to Aplastic Anemia/Paroxysmal Nocturnal Hemoglobinuria Syndrome: A Rare Case. [PDF]

Diagnostics (Basel)
Liu X, Li X, Chen Y, Huang R.
europepmc   +1 more source

Real-World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry. [PDF]

Am J Hematol
Röth A, Patriquin CJ, Szer J, Terriou L, Patel AS, Metzger J, Gustovic P, Nishimura JI, Brodsky RA.   +8 more
europepmc   +1 more source

Population PK-PD Modeling of Danicopan Add-On Therapy in Participants With Paroxysmal Nocturnal Hemoglobinuria Treated With Ravulizumab or Eculizumab. [PDF]

CPT Pharmacometrics Syst Pharmacol
Chen J, Yang F, Li H, Pradhan R, Ortiz S.   +4 more
europepmc   +1 more source

The varieties of therapeutic experience: navigating treatment options for patients with PNH. [PDF]

Hematology Am Soc Hematol Educ Program
Bienz M, Patriquin CJ.
europepmc   +1 more source

Clinical characteristics and management of paroxysmal nocturnal hemoglobinuria in the Middle East: a narrative review. [PDF]

Clin Exp Med
Almakadi M, AlHashim N, Al-Khabori M, Alzahrani H, Osman HY, Mattar M, Sabah A.   +6 more
europepmc   +1 more source

Efficacy and safety of cyclosporine plus luspatercept versus cyclosporine in newly diagnosed non-transfusion-dependent non-severe aplastic anemia: A prospective randomized trial. [PDF]

BMC Med
Zhang Z, Hu Q, Wang L, Yang C, Chen M, Han B.   +5 more
europepmc   +1 more source